Home » Topics » BioWorld Science

BioWorld Science
RSS

ViroPharma files NDA for pleconaril for the treatment of viral respiratory infection in adults

Aug. 3, 2001

Letrozole may increase adult height in boys with delayed puberty

Aug. 3, 2001

Polydex reports latest advancements for development of Usherdex for lung disorders

Aug. 3, 2001

Abbott Laboratories submits NDA for Synthroid ahead of schedule

Aug. 3, 2001

Novel leukemia drug receives positive opinion from CPMP

Aug. 3, 2001

FDA approves DuPont Pharmaceutical's ultrasound contrast agent Definity

Aug. 3, 2001

Long-terms effects of Ac-SDKP assessed in rat model of renovascular hypertension

Aug. 3, 2001

Phase I trial of oral gluconeogenesis inhibitors for diabetes mellitus set to begin

Aug. 3, 2001

Texas Biotechnology announces approval of argatroban in Canada

Aug. 3, 2001

Early c-Fos induction appears to have neuroprotective role in cerebral ischemia

Aug. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...